dihexa structure Dihexa Capsules - 5mg -

Improved blood sugar control and weight loss in T2D: A 32-week phase 2 trial, involving 92 participants with T2D, revealed that weekly doses of 2.4 mg cagrilintide + semaglutide reduced HbA1c levels by -2.2%, fasting blood sugar by -3.3 mmol/L, and body weight by -15.6% from baseline [12]

Total marker baseline Comprehensive bloodwork and advanced assessments covering hormones, metabolic markers, inflammation, nutrition, and longevity-specific indicators that standard labs simply don't run

The method of any one of claims 78-81 , wherein the subject is human

These statements have not been evaluated by the Food and Drug Administration.